Author Correction: Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
In the original version of the Supplementary Information file associated with this Article, the sequence ‘1x MS2 scRNA.b2’ was incorrectly given as ‘GAAGATCCGGCCTGCAGCCAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCGCACATGAGGATCACCCATGTGCTTTTTT’ and should have read ‘GAAGATCCGGCCTGC...
Guardado en:
Autores principales: | Chen Dong, Jason Fontana, Anika Patel, James M. Carothers, Jesse G. Zalatan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/495fd8fb626042c6b73dc60110c5192b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Chen Dong, et al.
Publicado: (2018) -
Effective CRISPRa-mediated control of gene expression in bacteria must overcome strict target site requirements
por: Jason Fontana, et al.
Publicado: (2020) -
Author Correction: Repurposing type I–F CRISPR–Cas system as a transcriptional activation tool in human cells
por: Yuxi Chen, et al.
Publicado: (2020) -
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
por: Francis P. Pankowicz, et al.
Publicado: (2016) -
Digital logic circuits in yeast with CRISPR-dCas9 NOR gates
por: Miles W. Gander, et al.
Publicado: (2017)